Showing results (681-690 of 912) with videos related to

Sort By:
Pageof 92
Journal of the American College of Cardiology|September 11, 2020
Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT TrialRebecca T Hahn, Federico Asch, Neil J Weissman, et al.
Acta Diabetologica|March 4, 2020
Embryonic stem cell extracts improve wound healing in diabetic miceCristian Loretelli, Moufida Ben Nasr, Giorgio Giatsidis, et al.
Cancers|April 14, 2025
Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics in a Nursing StaffAntonella Guido, Laura Peruzzi, Matilde Tibuzzi, et al.
Cardiovascular Research|June 24, 2015
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligationGiovanni Esposito, Gabriele Giacomo Schiattarella, Cinzia Perrino, et al.
Journal of Clinical Medicine|December 9, 2023
A Meta-Analysis of Short-Term Outcomes of TAVR versus SAVR in Bicuspid Aortic Valve Stenosis and TAVR Results in Different Bicuspid Valve AnatomiesRiccardo Improta, Gianluca Di Pietro, Novis Kola, et al.
Nature Communications|June 13, 2018
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatmentDiego Scheggia, Rosa Mastrogiacomo, Maddalena Mereu, et al.
Frontiers in Bioengineering and Biotechnology|March 30, 2026
New frontiers in porcine atrioventricular node decellularization: preserving extracellular matrix architecture for biological scaffoldsAlice Tomas, Assunta Fabozzo, Domenico Ventrella, et al.
Cell Death & Disease|February 12, 2019
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcomaMarlene Dallmayer, Jing Li, Shunya Ohmura, et al.
Nature Communications|August 31, 2018
Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatmentDiego Scheggia, Rosa Mastrogiacomo, Maddalena Mereu, et al.
Oncotarget|February 9, 2018
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targetsMichaela C Baldauf, Martin F Orth, Marlene Dallmayer, et al.
Pageof 92